Workflow
苏试试验(300416) - 2020 Q3 - 季度财报
STISTI(SZ:300416)2020-10-27 16:00

Financial Performance - Operating revenue for the period reached CNY 311,935,163.41, a 79.88% increase year-on-year[8] - Net profit attributable to shareholders was CNY 27,899,649.19, up 43.77% compared to the same period last year[8] - Basic earnings per share rose by 35.71% to CNY 0.1372[8] - Total revenue for the current period is ¥152,226,322.16, which is a significant increase from ¥95,521,677.76 in the previous period, marking a growth of around 59.5%[59] - The net profit attributable to the parent company is ¥27,899,649.19, up from ¥19,405,995.24, reflecting a growth of about 43.5%[59] - The total profit for the current period was ¥101,252,928.85, compared to ¥71,148,171.01 in the previous period, showing strong growth[74] Asset and Equity Changes - Total assets increased by 6.44% to CNY 2,401,615,617.30 compared to the end of the previous year[8] - Net assets attributable to shareholders increased by 17.49% to CNY 992,329,434.81 compared to the end of the previous year[8] - The total equity attributable to the owners of the parent company rose to ¥818,390,399.17, compared to ¥697,429,780.93 in the previous year, marking an increase of around 17.3%[49] - The total equity attributable to shareholders was CNY 844,627,599.45, with minority interests of CNY 93,967,699.18, leading to total equity of CNY 938,595,298.63[104] Cash Flow and Investments - Net cash flow from operating activities increased by 34.31% to CNY 47,224,349.26[8] - The company reported a significant increase in cash flow from operating activities, up 173.32% year-to-date[8] - Cash inflow from operating activities totaled CNY 827,222,544.72, compared to CNY 410,182,023.74 in the previous period, representing a 101.0% increase[84] - Cash outflow from investing activities amounted to CNY 413,867,186.93, compared to CNY 205,303,384.26 in the previous period, indicating a 101.0% increase in investment spending[86] - Cash inflow from financing activities reached CNY 867,662,487.43, up from CNY 394,079,655.18, marking a 120.5% increase[86] Liabilities and Financial Expenses - The company's total liabilities increased to ¥1,174,061,155.56 from ¥1,090,134,850.60, reflecting a rise of approximately 7.7%[49] - Long-term borrowings increased by 318.38% compared to the beginning of the period, primarily due to acquisition loans[24] - Financial expenses increased by 147.62% year-on-year, mainly due to increased interest from financing activities[24] Research and Development - Research and development expenses increased by 58.56% year-on-year, reflecting ongoing investment in innovation[24] - Research and development expenses for the quarter were ¥22,833,552.52, up from ¥12,896,495.57, representing an increase of about 77%[53] - Research and development expenses have risen to ¥9,705,897.58 from ¥4,613,053.96, showing an increase of approximately 110.0%[59] - Research and development expenses increased to ¥17,167,578.95 from ¥14,308,337.64, reflecting a focus on innovation[78] Shareholder Information - The top ten shareholders hold a combined 42.34% of the shares, with the largest shareholder owning 86,100,000 shares[12] - The company issued convertible bonds amounting to 231,522,736.61 yuan during the reporting period[24] Operational Efficiency - Operating costs increased by 78.88% year-on-year, consistent with revenue growth[24] - The company's total operating costs for the current period are ¥729,496,987.86, compared to ¥422,992,351.89 in the previous period, indicating an increase of approximately 72.3%[67] - The net profit margin improved significantly, with total operating costs rising to ¥281,720,573.55 from ¥150,510,954.85, reflecting a more efficient cost management strategy[53] Compliance and Adjustments - The company adjusted its financial statements to comply with the new revenue recognition standards, reclassifying "prepayments" to "contract liabilities"[104] - The implementation of new revenue recognition standards began on January 1, 2020, affecting the presentation of contract liabilities[114]